Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat for Preventing Postoperative ARDS in Cardiac Surgery
NCT06276569Phase 3Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Feb 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sivelestat in acute respiratory distress syndrome (ARDS), acute lung injury (ALI), sponsored by Nanjing Drum-Tower Hospital. Started Feb 2024; status: completed.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)acute lung injury (ALI)
Beyond the preview
Go deeper on NCT06276569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06276569.